Paolo Petreni
Siena, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Somatostatin analogs in pregnant patients with neuroendocrine tumor.
Journal: Anti-cancer drugs
Published: June 27, 2020
In Regard to "Activity of EGFR TKIs in Caucasian Patients With NSCLC Harbouring Potentially Sensitive Uncommon EGFR Mutations".
Journal: Clinical lung cancer
Published: December 23, 2019
ROS1 rearrangements are uncommon in biliary tract cancers.
Journal: Oncology letters
Published: August 14, 2019
Effects of a home-based exercise rehabilitation program for cancer survivors.
Journal: The Journal of sports medicine and physical fitness
Published: October 09, 2018
Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 30, 2017
Osteonecrosis of the Jaw and Angiogenesis inhibitors: A Revival of a Rare but Serous Side Effect.
Journal: Current medicinal chemistry
Published: December 16, 2016
First-line treatment of NSCLC with bevacizumab: real world data from an Italian regional based survey.
Journal: Journal of chemotherapy (Florence, Italy)
Published: October 01, 2016
Emerging drugs in refractory colorectal cancer.
Journal: Future medicinal chemistry
Published: August 22, 2015
A new proteomic test could guide treatment decision in second-line therapy for patients with EGFR unselected non-small cell lung cancer?
Journal: Annals of translational medicine
Published: December 23, 2014
Outcome of crizotinib treatment in a young woman with heavily pretreated ROS1-positive lung cancer.
Journal: Tumori
Published: December 02, 2014
Gallbladder neuroendocrine neoplasm: a case report and critical evaluation of WHO classification.
Journal: Endocrine journal
Published: August 05, 2014
Last Updated: 09/26/2026